Zhou T, Zhu C, Zhang W, Wu Q, Deng M, Jiang Z
Front Immunol. 2025; 16:1511529.
PMID: 39917301
PMC: 11799275.
DOI: 10.3389/fimmu.2025.1511529.
He J, Du M, Bi X, Chen P, Li J, Tian R
Am J Clin Exp Urol. 2025; 12(6):352-366.
PMID: 39839750
PMC: 11744353.
DOI: 10.62347/XVZJ5704.
Gao C, Zhang C, Wen L, Zhang G, Liu X, Wang J
Sci Rep. 2025; 15(1):2165.
PMID: 39820483
PMC: 11739689.
DOI: 10.1038/s41598-025-85460-x.
Chen X, Han Q, Song J, Pu Y
Medicine (Baltimore). 2025; 103(47):e40608.
PMID: 39809219
PMC: 11596697.
DOI: 10.1097/MD.0000000000040608.
Zheng Y, Fang M, Sanan S, Meng X, Huang J, Qian Y
J Inflamm Res. 2024; 17:10681-10697.
PMID: 39677287
PMC: 11638479.
DOI: 10.2147/JIR.S493889.
Constructing a prognostic model for hepatocellular carcinoma based on bioinformatics analysis of inflammation-related genes.
Li Y, Fang Y, Li D, Wu J, Huang Z, Liao X
Front Med (Lausanne). 2024; 11:1420353.
PMID: 39055701
PMC: 11269197.
DOI: 10.3389/fmed.2024.1420353.
Identification and functional analysis of lactic acid metabolism-related differentially expressed genes in hepatocellular carcinoma.
Li H, Qian F, Bao S
Front Genet. 2024; 15:1390882.
PMID: 38689649
PMC: 11058226.
DOI: 10.3389/fgene.2024.1390882.
Bioinformatics-driven identification and validation of diagnostic biomarkers for cerebral ischemia reperfusion injury.
Yang Y, Duan Y, Jiang H, Li J, Bai W, Zhang Q
Heliyon. 2024; 10(7):e28565.
PMID: 38601664
PMC: 11004763.
DOI: 10.1016/j.heliyon.2024.e28565.
Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
Dai Q, Zhu J, Yang J, Zhang C, Yang W, Pan B
Curr Stem Cell Res Ther. 2024; 20(1):103-122.
PMID: 38561604
DOI: 10.2174/011574888X305642240327041753.
Bioinformatics and Machine Learning Methods Identified MGST1 and QPCT as Novel Biomarkers for Severe Acute Pancreatitis.
Sun Y, Xie J, Zhu J, Yuan Y
Mol Biotechnol. 2024; 66(5):1246-1265.
PMID: 38236462
DOI: 10.1007/s12033-023-01026-0.
A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma.
Guo Z, Xie Y, Zhang L, Liu S, Jiang W
Aging (Albany NY). 2024; 16(1):267-284.
PMID: 38180745
PMC: 10817373.
DOI: 10.18632/aging.205367.
Comprehensive analysis reveals key genes and environmental toxin exposures underlying treatment response in ulcerative colitis based on analysis and Mendelian randomization.
Huang Y, Liu J, Liang D
Aging (Albany NY). 2023; 15(23):14141-14171.
PMID: 38059894
PMC: 10756092.
DOI: 10.18632/aging.205294.
Prognostic Model and Tumor Immune Microenvironment Analysis of Complement-Related Genes in Gastric Cancer.
Gu X, Shen H, Zhu G, Li X, Zhang Y, Zhang R
J Inflamm Res. 2023; 16:4697-4711.
PMID: 37872955
PMC: 10590588.
DOI: 10.2147/JIR.S422903.
Development and validation of a novel nomogram to predict the risk of the prolonged postoperative length of stay for lumbar spinal stenosis patients.
Yasin P, Cai X, Mardan M, Xu T, Abulizi Y, Aimaiti A
BMC Musculoskelet Disord. 2023; 24(1):703.
PMID: 37660009
PMC: 10474765.
DOI: 10.1186/s12891-023-06822-y.
Machine learning-based prediction of diagnostic markers for Graves' orbitopathy.
Cai Y, Su H, Si Y, Ni N
Endocrine. 2023; 81(2):277-289.
PMID: 37059863
PMC: 10293385.
DOI: 10.1007/s12020-023-03349-z.
A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.
Chen S, Liu P, Zhao L, Han P, Liu J, Yang H
Front Immunol. 2022; 13:954653.
PMID: 36189204
PMC: 9521313.
DOI: 10.3389/fimmu.2022.954653.
Prognostic role of NLGN2 and PTGDS in medulloblastoma based on gene expression omnibus.
Ren Z, Gao M, Jiang W
Am J Transl Res. 2022; 14(6):3769-3782.
PMID: 35836891
PMC: 9274574.